DARATUMUMAB

Overview

DARATUMUMAB is a Schedule H drug.
Daratumumab is a monoclonal antibody that blocks a certain protein in the body that can affect tumor cell growth. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage. Daratumumab is used to treat multiple myeloma (bone marrow cancer).

Usage

DARATUMUMAB is generally used to treat: Multiple Myeloma

Frequently Asked Questions

Q: Is it safe on my liver?
A: Check with your Doctor first

Q: Is it safe on my kidney?
A: Check with your Doctor first

Q: Can I take it with alcohol?
A: Not Safe

Q: Is it safe for children?
A: Ask your doctor

Q: Can it be taken during pregnancy?
A: Not enough studies to prove Risk – Ask your Doctor

Q: Is it safe to take for someone breastfeeding?
A: Check with your Doctor first

How Do I Take It?

Route of Administration: IV (Intravenous)

Precautions

Avoid contact with people who have infections that may spread to others (such as chicken pox,, measles,flu). Consult your doctor if you have been exposed to an infection or for more details.

Symptoms of Overdosage

DARATUMUMAB over-dosage can result in: Difficulty Breathing

Common Side-Effects

DARATUMUMAB : Hives, Confusion, Dizziness, Fainting, Body Excessive Sweating, Fatigue (tiredness), Weakness (generalized)

Serious Side-Effects

DARATUMUMAB : Eyes Blurred Vision, Chest Pain, Dizziness, Head Headache, Nausea, Vomit, Rapid Heart Rate (pulse), Throat Soreness, Difficulty Breathing

Food Interactions

No content

Disease Interactions

DARATUMUMAB can interfere with: Neutropenia, Thrombocytopenia, COPD

Technical Classification

DARATUMUMAB is categorized as: CD38 MONOCLONAL ANTIBODIES / ANTINEOPLASTICS

Available Alternatives

What are the other drugs with similar Ingredients?

DARATUMUMAB

DARATUMUMAB